Three Stocks Wall Street May be Overlooking: Risks and Alternatives

Wall Street is bullish on Leggett & Platt (LEG), NN (NNBR), and Jazz Pharmaceuticals (JAZZ), but there are concerns about their performance. LEG's sales have stagnated, earnings per share fell 12.7% annually over the last five years, and returns on capital are weak. NN's sales tumbled 7.4% annually over the last two years, earnings per share fell 18.8% annually, and cash burn is a concern. JAZZ's annual revenue growth of 4.7% over the last two years was below standards for the healthcare sector, and new share issuances caused earnings per share to fall 8.7% annually.